242 | 0 | 11 |
下载次数 | 被引频次 | 阅读次数 |
目的 编制以中医古代经典方为评价对象的证据质量评级量表,检验其信度、效度并加以应用,为临床实践指南的制定提供多来源的证据支持。方法 通过文献检索,提取并筛选现有文献中的评价维度,然后通过主题分析法归纳总结初始条目。遴选临床医学、医史文献学等领域的专家参与德尔菲问卷调研,进行条目的评价及筛选,开展专家共识会议确定最终纳入的条目。细化条目的评价方法及证据等级的划分方法,形成中医古代经典方证据质量评级量表,并进行信度、效度检验。结果 通过文献资料检索、提取、筛选和总结,共形成3个维度和12个初始条目。邀请69名专家对初始条目进行评价,问卷回收率为100%,专家权威系数为0.92,12项条目重要性评分均>4,故予以保留,形成了包含3个维度12个条目的中医古代经典方证据质量评级量表,3个维度分别是古代证据情况、传承情况和现代应用情况,每个维度包含4个评价条目,每个条目满分为5分,根据最终评分划分高、中、低级证据。量表的12个条目水平的内容效度均>0.9,量表平均内容效度指数为0.98,组内相关系数为0.90。结论 本研究编制的中医古代经典方证据质量评级量表具有良好的信度和效度,应用过程中具备可操作性,可在中医指南的制定过程中加以运用,更好地辅助临床决策。
Abstract:Objective To develop the Evidence Grading Scale for Ancient classical prescriptions in Traditional Chinese medicine, assess its reliability and validity, and apply it in practice to provide multi-source evidence for clinical practice guidelines development. Methods Literature retrieval was conducted to extract and screen existing evaluation dimensions, then the initial items were summarized using thematic analysis. Experts in the clinical medicine, medical history and literature participated in the Delphi questionnaire survey to evaluate and refine the items. An expert consensus meeting was conducted to finalize the included items, refine the method for items evaluation and evidence grading. The evidence quality rating scale for ancient classical traditional Chinese medicine(TCM) prescriptions was then established and tested for reliability and validity. Results Through literature review, extraction, screening and summarization, a total of 3 dimensions and 12 initial items were formed. Questionnaires were sent to 69 experts to evaluate the initial items, with a questionnaire response rate of 100% and an expert authority coefficient of 0. 92. All 12 items were retained for they had importance scores above 4. The Evidence Grading Scale on Ancient classical prescriptions in Traditional Chinese medicine includes 3 dimensions with 12 items. The 3 dimensions includes ancient evidence, inheritance status, and modern application. Each dimension contains 4 items, and each item has a full score of 5 points. The evidence was rated as high-level, moderate-level, and low-level according to the final scores.The content validity index(CVI) of the 12 items was >0. 9, the average CVI of the scale was 0. 98, and the intraclass correlation coefficient(ICC) was 0. 90. Conclusion The Evidence Grading Scale on Ancient classical prescriptions in Traditional Chinese medicine has good reliability and validity, which is practical for use in the development of TCM clinical guidelines and can better support clinical decision-making.
[1]刘建平.传统医学证据体的构成及证据分级的建议[J].中国中西医结合杂志,2007,27(12):1061-1065.
[2]陈薇,方赛男,刘建平.基于证据体的中医药临床证据分级标准建议[J].中国中西医结合杂志,2019,39(3):358-364.
[3]吕中茜,郭义,陈泽林,等.针灸临床实践指南制订中证据体的评估方法探索:分层证据评分法[J].中国针灸,2018,38(10):1115-1118.
[4]张磊,曾宪涛,佟琳,等.运用循证医学原则制定中医古籍证据评价分级量表的思路[J].中华中医药杂志,2020,35(6):2971-2973.
[5]刘少南,郭新峰,吴大嵘,等.中医干预类临床证据分级系统构建思路探讨[J].中医杂志,2023,64(18):1885-1889.
[6]李依洁,贾可欣,刘闰平,等.五法经典方辨治肝纤维化的现代药理作用研究概况[J].中草药,2022,53(16):5193-5204.
[7]任钧国,刘建勋.中药复方新药组方设计思路与方法[J].中国中药杂志,2015,40(17):3413-3415.
[8]ROMERO-COLLADO A.Essential elements to elaborate a study with the (e)Delphi method[J].Enferm Intensiva(Engl Ed),2021,32(2):100-104.
[9]GORDIJN SJ,BEUNE IM,THILAGANATHAN B,et al.Consensus definition of fetal growth restriction:a Delphi procedure[J].Ultrasound Obstet Gynecol,2016,48(3):333-339.
[10]张颖,季聪华,李秋爽,等.中医临床实践指南制修订中德尔菲法的统计分析方法[J].中华中医药杂志,2018,33(1):249-251.
[11]毛歆,杨悦,张河战.医药卫生领域能力评价工具研究概述[J].中国医药导报,2017,14(25):46-50.
[12]姚钰宁,曹克刚,托托,等.基于专家问卷的中医古籍证据分级及推荐方法的构建[J].中医杂志,2021,62(7):572-576.
[13]张磊.中医古籍防治证据评价分级量表的研制及应用[D].北京:中国中医科学院,2019.
[14]单帅帅,王庆伟,文建国.临床指南和专家共识的基本概念与制定规范[J].中华小儿外科杂志,2020,41(2):107-111.
[15]LYNN MR.Determination and quantification of content validity[J].Nurs Res,1986,35(6):382-385.
[16]罗园,张华,王三香,等.养老机构老年人跌倒风险综合评估工具的研制与检验[J].中国全科医学,2025,28(4):491-498.
基本信息:
DOI:10.13288/j.11-2166/r.2025.08.009
中图分类号:R289
引用信息:
[1]张居文,刘建平,苏祥飞等.中医古代经典方证据质量评级量表的研制及应用[J].中医杂志,2025,66(08):804-810.DOI:10.13288/j.11-2166/r.2025.08.009.
基金信息:
国家重点研发计划(2023YFC3503604)